Advent International, a private equity firm, agreed to acquire a majority stake in ZCL Chemicals, a pharmaceutical company in India from Morgan Stanley Private Equity Asia, a private equity platform. Financial terms were not disclosed. “In the last 12 years we have established ZCL as one of the leading pure-play API companies in the country, and today marks an important milestone in these efforts. We are very excited for the future of ZCL, and strongly believe Advent’s global expertise in the pharmaceutical space, combined with ZCL’s strong capabilities in manufacturing and R&D and a culture of customer centricity, will ensure that we keep up our tradition of delivering immense customer value,” Nihar Parikh, ZCL Chemicals Executive Director.